Committee presses for more analysis on opportunity zones, QSBS and R&D tax treatment; no final votes

Joint Standing Committee on Taxation · March 4, 2026

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Members sought additional fiscal and implementation information on the governor’s proposals for enhanced opportunity zone incentives, an expanded qualified small business stock exclusion, and the R&D expensing phase‑in; the items were deferred for further study.

The taxation committee devoted substantial time to three linked, high‑profile items — opportunity zones (item 24), the qualified small business stock expansion (item 19), and the federal change to research‑and‑development expensing (item 10) — but took no final votes and asked staff for additional analysis.

Mo Terry, legislative liaison for the Department of Economic and Community Development, told the committee that state evidence of opportunity zone effectiveness is limited and largely anecdotal because investment data are private; DECD has been consulting developers, CPAs and investors and expects updated mapping/designations in coming months. "Not really," Terry said when asked whether there was strong empirical evidence the zones had produced measurable state benefits, adding that the department is collecting anecdotal feedback and will offer more detail when available.

Dan Pittman (associate tax policy counsel) and Michael Allen (associate commissioner) walked members through technical complications in separating complex federal provisions. On R&D expensing, Allen described the governor’s approach: immediate full conformity for small businesses (gross receipts up to $31 million) and a multi‑year phase‑in for larger businesses; staff told members most of the fiscal impact resides with larger firms and that thresholds and administrative consequences would require follow‑up study.

Representative Brett Freeman moved to conform for small businesses only and not to adopt the phase‑in for larger firms; members asked MRS and Office of Tax Policy to supply a breakdown of the fiscal note that isolates small‑business impacts versus large‑business phase‑in costs.

On qualified small business stock (QSBS), staff cautioned that the federal change applies only to stock issued after a mid‑2025 cut‑off and involves multi‑year holding requirements, making Maine conformity a technical administrative decision with implications for firms and employees who hold stock as part of exit strategies. Staff highlighted choices: leave Maine law as the 2017 regime, adopt the 2025 federal changes, or eliminate the state exclusion, each with different administrative consequences and equity implications.

Committee direction: staff were asked to return with (a) a fiscal breakdown separating the small‑business portion of the R&D fiscal note, (b) administrative implications for implementing accelerated depreciation items independently, (c) metrics or anecdotal evidence on opportunity zone usage and effectiveness, and (d) scenarios showing how different QSBS conformity choices would affect taxpayers and the tax forms.

The committee postponed votes on these three items to allow for more precise fiscal and administrative estimates; Chair Grohowski asked staff to prioritize the requests and bring back written analyses before the next convening.